Revenue $1.88B, up 6.3% on a year earlier. Backlog $22.14B, down 4.5%. Funded backlog $3.82B, up 6.1%. Diluted EPS $2.38 against $2.71.
| Q2 FY27 | Q1 FY27 | Q2 FY26 | Year over year | |
|---|---|---|---|---|
| Revenue | $1.88B | $1.91B | $1.77B | +6.3% |
| Operating income | $152.00M | $179.00M | $139.00M | +9.4% |
| Net income | $102.00M | $115.00M | $127.00M | -19.7% |
| Diluted EPS | $2.38 | $2.61 | $2.71 | |
| Operating cash flow | $146.00M | $127.00M | $122.00M | +19.7% |
| Capital expenditures | -$15.00M | -$9.00M | -$7.00M | |
| Free cash flow | $131.00M | $118.00M | $115.00M | +13.9% |
| Dividend per share | $0.37 | $0.37 | $0.37 |
| Q2 FY27 | Q2 FY26 | Year over year | |
|---|---|---|---|
| Backlog | $22.14B | $23.17B | -4.5% |
| Funded backlog | $3.82B | $3.60B | +6.1% |
| Negotiated unfunded backlog | $18.32B | $19.58B | -6.4% |
| Revenue Growth | 6% | -2.7% | |
| Book-to-bill ratio | 0.6 | 1.5 | -60.0% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Science Applications International (SAIC) Q2 FY27 earnings: results and KPIs”, stockatlas.com/companies/SAIC/earnings/2027-q2/, data as of 3 November 2026. Links to this page are welcome.
